EUR 0.23
(10.1%)
Year | Net Income | Net Income Growth |
---|---|---|
2022 | -983.06 Thousand EUR | 99.73% |
2021 | -358.41 Thousand EUR | 47.83% |
2020 | -686.97 Thousand EUR | 36.38% |
2019 | -1.07 Million EUR | -119729.6% |
2018 | -901.08 EUR | 23.75% |
2017 | -1181.69 EUR | -256.03% |
2016 | 757.37 EUR | 213.67% |
2015 | -666.31 EUR | 9.88% |
2014 | -739.40 EUR | 99.94% |
2013 | -1.22 Million EUR | 24.68% |
2012 | -1.63 Million EUR | -25.35% |
2011 | -1.3 Million EUR | 4.21% |
2010 | -1.35 Million EUR | 36.25% |
2009 | -2.13 Million EUR | 26.34% |
2008 | -2.89 Million EUR | -69.23% |
2007 | -1.71 Million EUR | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2023 Q2 | - EUR | 0.0% |
2022 Q2 | -255.26 Thousand EUR | 0.0% |
2022 Q4 | -727.81 EUR | 0.0% |
2022 FY | -983.07 EUR | 99.73% |
2021 Q2 | -154.58 Thousand EUR | 0.0% |
2021 Q4 | -203.83 Thousand EUR | 0.0% |
2021 FY | -358.41 Thousand EUR | 47.83% |
2020 FY | -686.97 Thousand EUR | 36.38% |
2020 Q2 | -342.64 Thousand EUR | 0.0% |
2020 Q4 | -344.32 Thousand EUR | 0.0% |
2019 Q2 | -477.1 Thousand EUR | 0.0% |
2019 FY | -1.07 Million EUR | -119729.6% |
2019 Q4 | -602.65 Thousand EUR | 0.0% |
2018 FY | -901.08 EUR | 23.75% |
2018 Q4 | -520.04 EUR | 0.0% |
2018 Q2 | -381.05 EUR | 0.0% |
2017 Q2 | -468.09 EUR | 0.0% |
2017 Q4 | -713.60 EUR | 0.0% |
2017 FY | -1181.69 EUR | -256.03% |
2016 FY | 757.37 EUR | 213.67% |
2016 Q4 | 997.55 EUR | 0.0% |
2016 Q2 | -240.18 EUR | 0.0% |
2015 Q4 | -344.70 EUR | 0.0% |
2015 FY | -666.31 EUR | 9.88% |
2015 Q2 | -321.61 EUR | 0.0% |
2014 Q4 | -421.53 EUR | 0.0% |
2014 Q2 | -317.87 EUR | 0.0% |
2014 FY | -739.40 EUR | 99.94% |
2013 Q3 | -307.4 Thousand EUR | -39243.26% |
2013 Q4 | -448.28 EUR | 99.85% |
2013 Q2 | -781.35 EUR | 99.75% |
2013 FY | -1.22 Million EUR | 24.68% |
2013 Q1 | -307.4 Thousand EUR | 0.0% |
2012 Q3 | -408.14 Thousand EUR | 0.0% |
2012 FY | -1.63 Million EUR | -25.35% |
2012 Q1 | -408.14 Thousand EUR | 0.0% |
2012 Q2 | -408.14 Thousand EUR | 0.0% |
2011 Q3 | -325.6 Thousand EUR | 0.0% |
2011 Q2 | -325.6 Thousand EUR | 0.0% |
2011 Q1 | -325.6 Thousand EUR | 0.0% |
2011 FY | -1.3 Million EUR | 4.21% |
2010 Q2 | -339.92 Thousand EUR | 0.0% |
2010 Q3 | -339.92 Thousand EUR | 0.0% |
2010 Q1 | -339.92 Thousand EUR | 0.0% |
2010 FY | -1.35 Million EUR | 36.25% |
2009 FY | -2.13 Million EUR | 26.34% |
2009 Q3 | -533.23 Thousand EUR | 0.0% |
2009 Q2 | -533.23 Thousand EUR | 0.0% |
2009 Q1 | -533.23 Thousand EUR | 0.0% |
2008 Q1 | -723.95 Thousand EUR | 0.0% |
2008 Q2 | -723.95 Thousand EUR | 0.0% |
2008 Q3 | -723.95 Thousand EUR | 0.0% |
2008 FY | -2.89 Million EUR | -69.23% |
2007 Q2 | -427.8 Thousand EUR | 0.0% |
2007 Q1 | -427.8 Thousand EUR | 0.0% |
2007 Q3 | -427.8 Thousand EUR | 0.0% |
2007 FY | -1.71 Million EUR | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
aap Implantate AG | -5.12 Million EUR | 80.818% |
Drägerwerk AG & Co. KGaA | 110.43 Million EUR | 100.89% |
Drägerwerk AG & Co. KGaA | 110.43 Million EUR | 100.89% |
Eckert & Ziegler Strahlen- und Medizintechnik AG | 26.3 Million EUR | 103.738% |
Geratherm Medical AG | 1.11 Million EUR | 188.473% |
Koninklijke Philips N.V. | -466 Million EUR | 99.789% |
Stratec SE | 13.06 Million EUR | 107.523% |
Siemens Healthineers AG | 1.94 Billion EUR | 100.051% |